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Generation of High Density Protein
Microarrays by Cell-free in Situ Expression of
Unpurified PCR Products*
Philipp Angenendt‡§, Ju¨rgen Kreutzberger¶, Jo¨rn Glo¨kler, and Jo¨rg D. Hoheisel‡
Due to the success of DNA microarrays and the growing
numbers of available protein expression clones, protein
microarrays have become more and more popular for the
high throughput screening of protein interactions. How-
ever, the widespread applicability of protein microarrays
is currently hampered by the large effort associated with
their production. Apart from the requirement for a protein
expression library, expression and purification of the pro-
teins themselves and the lacking stability of many pro-
teins remain the bottleneck. Here we present an approach
that allows the generation of high density protein microar-
rays from unbound DNA template molecules on the chip.
It is based on the multiple spotting technique and com-
prises the deposition of a DNA template in a first spotting
step and the transfer of a cell-free transcription and trans-
lation mixture on top of the same spot in a second spot-
ting step. Using wild-type green fluorescent protein as a
model protein, we demonstrated the time and template
dependence of this coupled transcription and translation
and showed that enough protein was produced to yield
signals that were comparable to 300 g/ml spotted pro-
tein. Plasmids as well as unpurified PCR products can be
used as templates, and as little as 35 fg of PCR product
(22,500 molecules) were sufficient for the detectable
expression of full-length wild-type green fluorescent pro-
tein in subnanoliter volumes. We showed that both amin-
opropyltrimethoxysilane and nickel chelate surfaces can
be used for capture of the newly synthesized proteins.
Surprisingly we observed that nickel chelate-coated
slides were binding the newly synthesized proteins in an
unspecific manner. Finally we adapted the system to the
high throughput expression of libraries by designing a
single primer pair for the introduction of the required T7
promoter and demonstrated the in situ expression using
384 randomly chosen clones. Molecular & Cellular Pro-
teomics 5:1658–1666, 2006.
The understanding of complex cellular networks necessi-
tates tools that are amenable to the analysis of different
parameters in a highly parallel manner (1). Although in the last
years DNA microarrays were the technology of choice to
monitor the abundance of several thousands of mRNA tran-
scripts at a time, such studies provide us with little information
on the proteins that are encoded by these transcripts (2, 3).
However, because proteins rather than DNA carry out cellular
functions, there is large interest to analyze proteins and their
entirety, the proteome, in a manner comparable to DNA mi-
croarrays. One technology that is envisaged to meet the de-
mands of high throughput protein interaction and modification
screening is protein microarray technology (4–8).
Protein microarrays have been applied in different areas of
application, such as the analysis of protein-protein interac-
tions (9–11), the identification of substrates for protein ki-
nases (12–14), or the elucidation of potential diagnostic mark-
ers in bacterial or autoimmune diseases (15–18). All of them
share the basic principle of production. It involves the gener-
ation of expression clones and the subsequent expression
and purification of proteins off the chip followed by spotting
them onto the microarray surface. Currently this process rep-
resents a major bottleneck in the production of protein mi-
croarrays because both the generation of the expression
clones and the purification of the proteins are time- and
cost-intensive even in low throughput applications (19, 20).
To circumvent this bottleneck, different approaches have
been developed for the generation of protein microarrays.
Madoz-Gurpide et al. prepared cell lysate from adenocarci-
noma cell lines and fractionated the protein extract first by
anion exchange and then by reverse phase liquid chromatog-
raphy (21). The obtained fractions were then spotted and
probed with antibodies against different proteins. Although
this approach is truly advantageous with regard to proper
post-translational modifications of the proteins, only mixtures
of protein are displayed in which less abundant proteins may
not be detectable. He and Taussig (22, 23) introduced the idea
of creating protein arrays by cell-free transcription and trans-
lation of PCR products and the subsequent purification on
nickel chelate-coated surfaces. However, their approach,
termed “protein in situ array” (PISA), is limited by the large
volume of 25 l used for the expression and by the capture
process that is not performed on microarrays but on nickel
chelate-coated microtiter plates or magnetic agarose beads.
A miniaturization of cell-free transcription and translation as
an intermediate step toward the expression on the chip was
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reported by Angenendt et al. (24), who performed an expres-
sion and subsequent functional assay in 100-nl volumes. Ste-
ffen et al. (25) finally performed transcription on a chip using a
gene encoding enhanced green fluorescent protein. After
overlaying the chip with a transcription mixture, they were
able to detect the resulting mRNA in the mixture by RT-PCR.
Currently the only methodology for the production of pro-
tein microarray by expression of the proteins on the chip is the
nucleic acid programmable protein array (NAPPA)1 approach
(26). It entails the immobilization of plasmids containing the
cDNAs of interests as GST fusions on the surface in combi-
nation with an anti-GST capture antibody. The chip is then
overlaid with a cell-free expression mixture, which causes
expression of the protein and direct capture of the protein by
the antibody via the GST domain. The NAPPA process is very
cost-effective due to the small consumption of reagents and
allows the production of proteins just prior to the microarray
experiment, diminishing problems associated with the stor-
age of protein microarrays. Nevertheless it is limited by sev-
eral intrinsic drawbacks. For expression, NAPPA requires
plasmids that contain the gene of interest as a GST fusion.
This necessitates time-consuming cloning of cDNAs. More-
over it relies on the immobilization of the plasmid, which
requires a biotinylation of the plasmid at defined stoichiome-
tries to prevent dissociation from the array or a termination of
transcription by biotin incorporation within the coding se-
quence. In addition, only low density protein microarrays with
up to 512 spots per microscope slide can be produced be-
cause a higher density would cause proteins to diffuse to
capture antibodies of adjacent spots.
To overcome these problems, an optimized technology
should meet several criteria. (a) Expression should be directly
possible from a wide variety of different templates, including
PCR products. (b) Expression should be facile and inexpen-
sive. (c) The generation of protein microarrays should be
feasible within a short time period, just prior to their use, to
avoid storage effects. (d) Mode of binding should permit the
production of high density protein microarrays capable of
displaying several thousand proteins on a single microscopic
slide.
Here we present an approach that meets these demands. It
is based on the multiple spotting technique (MIST) (27) and
comprises the spotting of a DNA template in a first spotting
and the transfer of a cell-free transcription and translation
mixture on top of the very same spot in a second spotting run.
Using this technique, high density protein microarrays with up
to 13,000 spots per slide can be produced from a variety of
different sources in an uncomplicated and inexpensive
manner.
EXPERIMENTAL PROCEDURES
Materials—The Rapid Translation System (RTS) 100 Escherichia
coli HY kit was obtained from Roche Diagnostics GmbH. The plasmid
used for expression is an integral part of the kit and is based on the
pIVEX2.3 plasmid containing a gene encoding wild-type green fluo-
rescent protein (wt-GFP) fused to a C-terminal His6 tag (pIVEX-GFP).
PCR primers were synthesized by biomers.net GmbH, (Ulm, Ger-
many). PCR Buffer E was purchased from Genaxxon Bioscience
(Biberach, Germany), Taq polymerase was from Qiagen GmbH
(Hilden, Germany), and dNTPs were from Fermentas GmbH (St. Leon-
Roth, Germany).
Expression of GFP with Different Incubation Times—Dilutions of
the pIVEX-GFP plasmid in water were prepared ranging from 1
g/l to 1 ng/l. The dilutions as well as a negative control con-
taining only water were spotted on homemade aminopropyltrime-
thoxysilane (APTES) slides (prepared as described Ref. 28) using a
NanoPlotter 2.0 non-contact spotting system equipped with a with
a nanoliter pipette (Gesim mbH, Grosserkmannsdorf, Germany).
The volume that was dispensed per spot was 350 pl. After spotting
of the DNA template, the in vitro transcription and translation mix-
ture (RTS 100 mixture) was prepared without any template DNA as
recommended by the manufacturer and spotted onto the very same
position as the template DNA. In addition, the cell-free transcription
and translation mixture was spotted on negative control spots to
which only water had been dispensed. After spotting, the slides
were placed in humidified extradeep hybridization chambers
(TeleChem International Inc., Sunnyvale, CA) and incubated at
32 °C in a water bath for different incubation times. After incuba-
tion, the slides were blocked in 3% (w/v) fat-free milk powder/Tris-
buffered saline containing 0.1% (v/v) Tween 20 (TBS-T) for 15 min
on a shaker at room temperature. The slides were rinsed with TBS-T
and incubated for 30 min in 0.5 g/ml anti-GFP antibody (TP401,
Acris Antibodies, Hiddenhausen, Germany) diluted in blocking
buffer. After rinsing the slides with TBS-T, the slides were washed
twice for 5 min in TBS-T and dried by pressurized air. Scanning was
performed with a ScanArray 5000 (PerkinElmer Life Sciences).
Analysis was done using GenePix Pro 5.0. All signal intensities used
for analysis were signal intensities from which the local background
had been subtracted.
Determination of the Absolute Yield of Expression—PCR templates
containing the coding sequence of wt-GFP were generated by PCR of
the pIVEX-GFP plasmid. PCR was performed in 50-l volumes in
96-well polypropylene PCR plates (Steinbrenner Laborsysteme
GmbH, Wiesenbach, Germany) with the following primers: forward
primer, 5-GTGGCGAGCCCGATCTTC-3; reverse primer, 5-GTC-
AGGCACCGTGTATGAAATC-3.
The composition of the reaction was 1 Buffer E (67 mM Tris-HCl,
pH 8.8, 16 mM (NH4)2SO4, 2.5 mM MgCl2, 0.01% (v/v) Tween 20), 0.2
mM each dNTP, 0.2 M each primer, and 2.5 units of Taq polymerase.
Reactions were performed in a PTC-200 Thermocycler (Bio-Rad) at
the following temperatures: denaturation at 95 °C for 2 min; 40 cycles
of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 40 s; and a final
elongation step at 72 °C for 10 min.
PCR products were checked on agarose gels and purified using a
Qiaquick PCR purification kit (Qiagen GmbH). DNA was quantified by
absorption using a Nanodrop ND-1000 (Peqlab Biotechnologie
GmbH, Erlangen, Germany). Dilutions of the PCR were prepared from
20 ng/l to 100 pg/l using negative control PCR mixture (templates
were substituted by water) supplemented with 0.5 M betaine (final
concentration) for dilution. wt-GFP calibration curves ranging from 1
mg/ml to 2 g/ml were prepared by diluting conventionally obtained
wt-GFP with PBS and 0.5 M betaine (final concentration).
Expression and detection were done as described in the previous
paragraph with the following modifications. Nickel chelate-coated
1 The abbreviations used are: NAPPA, nucleic acid programmable
protein array; APTES, aminopropyltrimethoxysilane; MIST, multiple
spotting technique; wt-GFP, wild-type green fluorescent protein.
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slides (Xenopore, Hawthorne, NJ) were used as solid support. As a
negative control, the diluent used for the dilution series was used.
Expression was performed at 32 °C for 4 h, the slides were blocked in
3% (w/v) BSA in TBS-T, and detection was achieved by incubation of
the slides in 0.1 g/ml anti-penta-His antibody-Alexa Fluor 647 con-
jugate (Qiagen GmbH) diluted in blocking buffer for 1 h. Washing was
performed for 10 min in TBS-T, and the slides were rinsed with PBS
before scanning.
Effect of His Tagging on Nickel Chelate-coated Slides—A construct
lacking the C-terminal His6 tag was cloned using standard cloning
methodology. The resulting plasmid was named pIVEX-GFP-notag,
and the sequence was verified by sequencing. PCR of the pIVEX-GFP
and pIVEX-GFP-notag plasmids was performed using the same prim-
ers and cycling conditions as described before. The PCR products
were purified using a Qiaquick PCR purification kit (Qiagen GmbH)
and quantified. PCR products were diluted down to 10 ng/l in 10 mM
Tris (pH 8.5) containing 0.5 M (final concentration) betaine and 0.5
ng/l (final concentration) sonicated salmon sperm DNA (GE
Healthcare).
Detection was achieved as described in the previous paragraph
using a mixture of 0.1 g/ml anti-penta-His antibody-Alexa Fluor 647
conjugate and 0.5 g/ml anti-GFP antibody-Texas Red conjugate
(Ab6660, Abcam Plc, Cambridge, UK) in blocking buffer.
High Throughput Expression of cDNAs—384 cDNAs were ran-
domly chosen out of a human fetal brain library (hex-1) (29). Cells
were inoculated in 2YT medium (16 g/liter tryptone, 10 g/liter yeast
extract, 5 g/liter NaCl, pH 7.0) containing 100 g/ml ampicillin, 15
g/ml kanamycin, and 2% glucose and grown at 37 °C overnight.
Individual wells of 50-l volumes in 96-well polypropylene PCR plates
were inoculated with 1 l of bacterial culture. PCR was performed
with the following primers: forward primer, 5-GTAGCGGATCGAGT-
TCTCGATCCCGCGACACTAATACGACTCACTATAGGGAGACCAC-
AACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGA-
TATACCATGAGAGGATCGCATCACCATCACCATCAC-3; reverse
primer,
5-CGCGATCATGGCGACCACACCCGTCCTGTGGAGATCCAGATA-
TAGTTCCTCCTTTCAGCATCTCCGATGCGGATGTACTAAAAACCCC-
TCAAGACCCGTTTAGAGGCCCCAAGGGGTTCGACTCACTATAGG-
GAGCGG-3.
The composition of the reaction was 1 Buffer E (67 mM Tris-HCl,
pH 8.8, 16 mM (NH4)2SO4, 2.5 mM MgCl2, 0.01% (v/v) Tween 20), 0.2
mM each dNTP, 0.2 M each primer, 1 unit of Taq polymerase.
Reactions were performed in a PTC-200 Thermocycler (Bio-Rad) at
the following temperatures: denaturation at 95 °C for 10 min; 40
cycles of 95 °C for 60 s, 60 °C for 60 s, 72 °C for 120 s; and 72 °C for
10 min. Prior to spotting, 0.5 M (final concentration) betaine and 0.5
ng/l (final concentration) sonicated salmon sperm DNA were added
to the PCR products. Expression and detection were performed as
described under “Determination of the Absolute Yield of Expression”
above.
Protein expression in microtiter plates was performed with 48
clones in a reaction volume of 8 l/reaction in 96-well polypropylene
PCR plates. The transcription and translation mixture was prepared
as recommended by the manufacturer, and unpurified PCR products
diluted 1:2 in water were used as templates. Incubation of the mixture
was performed overnight at 30 °C in a PTC-200 Thermocycler fol-
lowed by spotting of the mixture on nickel chelate-coated slides. The
slides were stored overnight at 4 °C, and detection was performed as
described under “Determination of the Absolute Yield of Expression”
above.
RESULTS
Principle of Utilizing MIST for Expression—The in situ pro-
tein expression on the chip is based on the creation of sep-
arate reaction entities on each spot of the microarrays by
MIST (Fig. 1). In a first step, DNA templates are spotted on an
activated glass slide. On top of the DNA templates, a cell-free
transcription and translation mixture is spotted in a second
spotting run before the whole slide is incubated in a humid
hybridization chamber, which causes the spots to rehydrate
and the expression to start. After incubation, the slide is
blocked, and the expressed proteins are detected by specific
antibodies.
Dependence of the Expression on Incubation Time and Con-
centration of DNA Template—Transcription of DNA templates
into mRNA and its subsequent translation into protein are a
coupled enzymatic reaction mediated by T7 RNA polymerase
and a complex cascade of enzymes within the ribosomal com-
plex. As an enzymatic process, the amount of products that is
produced is dependent on two factors: the amount of substrate,
i.e. DNA template molecules, and time. To demonstrate this
principle, a dilution series of plasmid encoding wt-GFP was
applied to different APTES-coated microarrays. Then cell-free
transcription and translation mixture was spotted on top, and
the slides were incubated for different periods of time, starting
directly after application of the expression mixture; the longest
incubation was overnight (Fig. 2).
For analysis, the mean signal intensity of each dilution and
time point was calculated, and the mean signal intensity of the
negative control spots without template was subtracted (Fig.
3). The diagram shows an increase of signal intensity with
increasing concentration of template molecules for the varies
time points. In addition, an increase of signals with longer
incubation times of up to 2 h was observed, whereas there
was a slight loss of signal intensity after prolonged incubation
times, such as overnight. The coefficient of variation was
FIG. 1. Schematic outline of MIST.
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computed for all signals 1000 and was determined to be in
the range of 16–20%.
Determination of the Absolute Yield of Expression—To
quantify the absolute amounts of wt-GFP that are produced
and to demonstrate that unpurified PCR products can also be
used as DNA templates, the gene coding for wt-GFP was
amplified by PCR, and a dilution series was prepared. In a first
spotting run, the PCR products were spotted on nickel che-
late-coated slides. Then the cell-free expression mixture was
added. For absolute quantification, a dilution series of purified
wt-GFP was spotted on the very same set of slides for cali-
bration (Fig. 4). Detection was performed using an anti-penta-
His antibody, which recognizes the C-terminal His6 tag of
both the on- and off-chip produced wt-GFP. Because of the
terminal position of the His tag, only the quantification of
full-length wt-GFP was possible. To be able to compare the
signals from the expression of wt-GFP and the calibration
series, it was assumed that the binding characteristics of both
the newly synthesized wt-GFP and the purified wt-GFP were
identical. A graph of spotted PCR template concentration
versus expressed protein concentration was prepared by cal-
culation of the mean of the signal intensities of the expression
and normalizing them via the calibration data (Fig. 5). The graph
displays the suitability of unpurified PCR products for expres-
sion on a chip with a saturation of the signals above 0.5 ng/l
DNA yielding full-length wt-GFP in the range of 300 g/ml.
Effect of His Tagging on Nickel Chelate-coated Slides—
Surface activation of solid support plays a crucial role in the
expression on the chip because it must provide an environ-
ment that prevents complete blocking by DNA templates and
cell-free transcription and translation mixture on the one hand
and on the other hand permits the newly synthesized protein
to immobilize. APTES as well as nickel chelate coating were
evaluated, and both performed well (Figs. 2 and 4) with nickel
chelate displaying moderately brighter signals (data not
shown). To elucidate whether this effect was due to the ex-
pected affinity capture of the His6 tag or due to unspecific
binding, a wt-GFP construct lacking the C-terminal His6 tag
was generated. Both genes were amplified by PCR and spot-
ted on nickel chelate-coated slides. Detection was performed
simultaneously by an anti-penta-His-Alexa 647 antibody con-
jugate and an anti-GFP-Texas Red conjugate (Fig. 6). Direct
comparison of both constructs displayed comparable signal
FIG. 2. Dependence of on-chip expression on DNA template
concentration and incubation time. Different DNA concentrations
ranging from 1 g/l (top row) to 1 ng/l (second row from the
bottom) were applied to the microarray as well as a negative control
in which pure water was spotted (bottom row). In a second spotting
step, cell-free transcription and translation mixture was applied on
top of this template. Subsequently the slides were subjected to dif-
ferent periods of incubation ranging from 0 min to overnight. For
detection, an anti-GFP antibody was used.
FIG. 3. Diagram of plasmid concen-
tration versus signal intensity. For
computation, the background-sub-
tracted signals from Fig. 2 were quanti-
fied. The mean was calculated, and the
signals from the negative control were
subtracted.
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intensities for the anti-GFP antibody, whereas only the con-
struct with the His6 tag generated signals with the anti-penta-
His antibody.
High Throughput Expression of cDNAs—384 clones from a
human fetal brain expression library were randomly chosen to
elucidate whether the principle of the on-chip expression of
proteins could be extended to the high throughput expression
of proteins from an expression library. The clones were orig-
inally cloned in the pQE-30NST expression vector that carries
a phage T5 promoter and two lac operators for isopropyl
-D-thiogalactoside-inducible recombinant protein expres-
sion. In addition, the cDNAs were flanked by a T7 and an SP6
FIG. 5. Diagram of spotted PCR tem-
plate concentration versus expressed
protein concentration. The back-
ground-corrected signals obtained in
Fig. 4 were quantified and normalized
using the calibration series of wt-GFP.
FIG. 6. Effect of His tagging on nickel-chelate coated slides. To elucidate whether the His6 tag is promoting a specific and oriented
attachment to nickel-chelate slides, two wt-GFP constructs, one with and one without the His6 tag, were prepared and used for expression.
Detection was performed simultaneously with an anti-penta-His antibody-Alexa 647 conjugate and an anti-GFP Texas Red conjugate.
FIG. 4. Absolute quantification of expression yield. For the determination of the absolute expression yield, different concentrations of
unpurified PCR products ranging from 20–0.1 ng/l as well as a negative control were used for expression. In parallel, a dilution series of
purified wt-GFP was spotted for calibration. Detection was done with an anti-penta His antibody so that only full-length wt-GFP was identified.
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promoter for transcription in sense and antisense directions.
To make the cDNAs available for cell-free expression, they
were amplified directly from the colony by PCR using a single
primer pair harboring a T7 promoter along with the ribosomal
binding site and part of the T7 terminator sequence. This led
to a replacement of the original T5 promoter sequence as well
as the antisense T7 promoter and provided the cDNAs in a
format ready for spotting without any purification of the PCR
products. The DNA fragments were spotted in quadruplicates,
and detection was performed via their N-terminal His6 tag and
an anti-penta-His antibody (Fig. 7).
Expression of 24 clones showing high yields and 24 clones
without expression was also carried out in microtiter plates to
verify whether the unsuccessful expression of clones was due
to the microarray setup. After expression, the mixture was
spotted on nickel chelate slides, and an anti-penta-His anti-
body was applied for detection. All of the 24 clones showing
high expression on a chip were also expressed in the micro-
titer format (Fig. 8), and none of the 24 clones without expres-
sion on the chip displayed a detectable expression in the
microtiter plate.
DISCUSSION
The generation of high density protein microarrays is a
cost- and time-intensive process. Reasons for this are not so
much the spotting process itself but the production of the
FIG. 7. High throughput expression
of cDNAs. PCR of 384 randomly chosen
cDNAs was conducted with a single
primer pair introducing the required pro-
moter sequences. The PCR products
were used as templates in the subse-
quent in situ expression, and proteins
were visualized by their N-terminal His6
tag and an anti-penta-His antibody-
Alexa 647 conjugate. Negative control
reactions were performed by using water
instead of template in the PCR, and ex-
pression was performed in the two qua-
druplicates at the bottom right.
FIG. 8. Comparison of microarray-based and microtiter-based expression. 24 clones showing high expression yields in the in situ
expression and 24 clones without expression were selected and subjected to an expression in a microtiter format. After expression,
transcription and translation mixture containing the expressed proteins was spotted on nickel-chelate coated slides, and the resulting
recombinant proteins were detected by an anti-penta-His antibody-Alexa 647 conjugate. Scans from the 24 clones showing expression are
displayed for the in situ expression in a microarray setup (M) and for the microtiter-based expression (P). Negative control reactions lacking
any DNA template were performed in both formats and are shown at the bottom right. The 24 clones without detectable signals in the in situ
expression on the microarray did not show any expression in the microtiter setup.
Cell-free in Situ Expression
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proteins, which requires the generation of expression clones
and the subsequent expression and purification of the pro-
teins. Currently the only methodology to avoid this laborious
task is the NAPPA technique, which was introduced by Ra-
machandran et al. (26). Although this approach provides a
more feasible methodology than the separate expression and
purification of the proteins off the chip, it is still limited by
several intrinsic drawbacks. NAPPA requires the generation of
an expression library, which harbors the coding sequences as
GST fusions downstream of a T7 promoter. For expression,
these constructs have to be purified and biotinylated at de-
fined stoichiometries. In addition, the density of the resulting
protein microarrays is limited to 512 spots per microscopic
slide because at higher densities proteins might diffuse to
adjacent spots.
To overcome these limitations and to enable the generation
of high density protein microarrays with minimal manual in-
terference, we developed an alternate strategy for an in situ
expression of proteins. As a proof of principle, the expression
of a plasmid harboring wt-GFP on the chip was performed. To
demonstrate the dependence on time and amount of sub-
strate different concentrations of the plasmid were applied to
the chip, and the microarrays were incubated for different
periods of time. As a solid support, slides coated with APTES
were used because it has proven its ability to retain proteins
in microarray applications (28, 30, 31). As expected, an in-
crease of signal intensity was observed with increasing
amount of plasmid as well as increasing incubation times of
up to 2 h. Upon overnight incubation, the signals decreased
again. This may be caused by proteolytic degradation by
residual proteases of the cell-free transcription and translation
mixture. The control, in which water instead of DNA template
was spotted, resulted in very low signals, yielding signal to
control ratios of up to 270.
To evaluate the possibility of using unpurified PCR products
and to compute the absolute yield of expression, the gene
encoding wt-GFP was amplified by PCR, and different con-
centrations of PCR products were applied to nickel chelate-
coated glass slides. In parallel, a dilution series of purified
wt-GFP was spotted as a calibration sample (Fig. 4). For
detection, an antibody was used that recognizes the C-termi-
nal His6 tag of the wt-GFP, hence only recognizing full-length
protein. To be able to determine the absolute amount of
protein that is expressed and to compare the signals of the
expression with the ones obtained from the calibration set, we
inferred that the binding kinetics of the newly synthesized
wt-GFP and the purified GFP are identical. From both dilution
series, the signal intensities were determined, and a diagram
of expressed protein concentration versus spotted PCR tem-
plate concentration was drawn (Fig. 5). The diagram shows
that as little as 0.1 ng/l PCR product can be used for ex-
pression and that up to 300 g/ml protein or 3.7 fmol can be
produced on the spots. This amount seems to be remarkable
considering that the amino acids present in each droplet
would already limit synthesis to 30.67 fmol. If the purified
wt-GFP and the on-chip synthesized wt-GFP do not have
equal binding kinetics, it can be expected that the purified
wt-GFP will bind much more efficiently to the surface than the
newly synthesized wt-GFP, since the latter has to compete
with an excess of proteins from the cell-free transcription and
translation mixture. This would mean that even more wt-GFP
would have been produced so that equal amounts of protein
can be detected.
Capture of the newly synthesized wt-GFP onto the surface
is a crucial step in the in situ expression. Two surfaces,
APTES and nickel chelate, were used, and both demonstrated
their applicability. Although in the case of the APTES surface
the mode of binding is very likely to be unspecific ionic inter-
action, we wanted to test whether the binding of wt-GFP to
the nickel chelate surface is due to an affinity binding between
the His6 tag and the nickel chelate microarray as widely
applied in batch protein purification procedures (32, 33). The
nickel chelate surface has been reported to bind His-tagged
proteins in a specific and oriented manner in a microarray
setup (10, 34, 35). However, to our knowledge, it has not yet
been demonstrated that the binding is truly dependent on the
His tag. To test this, a wt-GFP construct was cloned that was
lacking the C-terminal His6 tag. An expression on the chip
was performed, and the resulting expression products were
detected simultaneously by an anti-GFP antibody and anti-
penta-His antibody (Fig. 6). Although the signals from the
anti-GFP antibody were comparable, the signal from the anti-
penta-His antibody was only detectable for the tagged wt-
GFP. This result points toward the fact that unspecific binding
of the protein is the major mode of binding rather than a
specific and oriented attachment via the His6 tag. This may be
due to electrostatic interactions because high salt buffer con-
ditions are often recommended for nickel-nitrilotriacetic acid
chromatography to reduce background binding of untagged
proteins.
To test whether the expression on a chip can be applied to
proteins other than wt-GFP, 384 clones were randomly picked
from a human fetal brain protein expression library. The cod-
ing sequences were amplified by PCR using a single primer
pair carrying a T7 promoter, a ribosomal binding site, and a T7
terminator. Expression was performed on the chip using the
unpurified PCR products as templates (Fig. 7). A multitude of
the coding sequences revealed successful expression after
detection by an anti-penta-His antibody, whereas negative
controls (two quadruplicates at the bottom right), in which no
template was added to the PCR, yielded signals in the back-
ground range. The comparison of in situ expression with
conventional expression revealed an identical distribution of
expressible and non-expressible clones, demonstrating that
the success rate of expression is not affected by the minia-
turization of the expression to subnanoliter volumes. This may
be attributed to the nature of the proteins, which may contain
hard-to-express secondary structures or structures that lead
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to misfolding and subsequent degradation (36). Moreover the
microarray-based expression seems to result in a more ho-
mogenous distribution of signal intensities in comparison with
the microtiter-based expression, which is beneficial in high
throughput analysis systems. Altogether the results show that
that the principle of in situ expression on a microarray can be
extended to a larger set of proteins and that the bottleneck
of protein array generation could be overcome by this
methodology.
In summary, we present an in situ expression of proteins on
a chip as a new application of the multiple spotting technique
that complements its application in the detection of proteins
and antibodies (27), in the selection of single chain Fv frag-
ments from phage display selections (37), and the character-
ization of enzymatic activities and inhibitors thereof (38). The
in situ expression involves the spotting of DNA templates in a
first spotting step followed by the spotting of a cell-free tran-
scription and translation mixture in a second spotting step on
top of the DNA templates. Rehydration of the spots creates
separated reaction entities in which the expressions can pro-
ceed. This allows the generation of high density protein mi-
croarrays with densities of up to 13,000 spots per slide. The
generation of templates by PCR permits the expression of
coding sequences without the laborious cloning in expression
vectors and facilitates the introduction of novel tags. In addi-
tion the PCR products can be used directly without purifica-
tion, which minimizes manual interaction steps.
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